Paper42379802
Inhibition of Plasminogen Activator Inhibitor-1 (PAI-1) by Tiplaxtinin Attenuates the Aggressive Phenotype of Vulvar Squamous Cell Carcinoma Cells In Vitro.
Warmbold J and 2 others. In Vivo, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Inhibition of Plasminogen Activator Inhibitor-1 (PAI-1) by Tiplaxtinin Attenuates the Aggressive Phenotype of Vulvar Squamous Cell Carcinoma Cells In Vitro. Papers, record 42379802. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42379802
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Inhibition of Plasminogen Activator Inhibitor-1 (PAI-1) by Tiplaxtinin Attenuates the Aggressive Phenotype of Vulvar Squamous Cell Carcinoma Cells In Vitro.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Plasminogen Activator Inhibitor 1 | Major topic |
| Carcinoma, Squamous Cell | Major topic |
| Vulvar Neoplasms | Major topic |
| Humans | |
| Female | |
| Cell Proliferation | |
| Cell Movement | |
| Cell Line, Tumor | |
| Apoptosis | |
| Cell Survival | |
| Gene Expression Regulation, Neoplastic | |
| Phenotype | |
| Indoleacetic Acids |
Source PubMed
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12023852 | Urokinase-type plasminogen activator: a potent marker of metastatic potential in human cancers. | Biochem Soc Trans | 2002 | https://conductscience.org/library/papers/12023852 | PubMed |
| 2 | 27154744 | GPER-novel membrane oestrogen receptor. | Clin Sci (Lond) | 2016 | https://conductscience.org/library/papers/27154744 | PubMed |
| 3 | 37762008 | Activation of G-Protein-Coupled Estrogen Receptor 1 (GPER1) Reduces Progression of Vulvar Carcinoma Cells. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37762008 | PubMed |
| 4 | 31846523 | Vulval squamous cell carcinoma and its precursors. | Histopathology | 2020 | https://conductscience.org/library/papers/31846523 | PubMed |
| 5 | 12784994 | Cell surface association of matrix metalloproteinase-9 (gelatinase B). | Cancer Metastasis Rev | 2003 | https://conductscience.org/library/papers/12784994 | PubMed |
| 6 | 39730177 | G Protein-coupled Estrogen Receptor 1 (GPER1) Regulates Expression of SERPINE1/PAI-1 and Inhibits Tumorigenic Potential of Cervical Squamous Cell Carcinoma Cells In Vitro. | Cancer Genomics Proteomics | 2025 | https://conductscience.org/library/papers/39730177 | PubMed |
| 7 | 39481051 | Advances in Vulvar Cancer Biology and Management. | J Clin Oncol | 2025 | https://conductscience.org/library/papers/39481051 | PubMed |
| 8 | 4357758 | In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. | J Natl Cancer Inst | 1973 | https://conductscience.org/library/papers/4357758 | PubMed |
| 9 | 12183417 | Enhanced benefit from adjuvant chemotherapy in breast cancer patients classified high-risk according to urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (n = 3424). | Cancer Res | 2002 | https://conductscience.org/library/papers/12183417 | PubMed |
| 10 | 32960779 | Modern treatment of vulvar cancer. | Radiol Oncol | 2020 | https://conductscience.org/library/papers/32960779 | PubMed |
| 11 | 38821614 | Clinical Impact of Pelvic Sentinel Lymph Node Biopsy for Vulvar Squamous Cell Carcinoma. | Anticancer Res | 2024 | https://conductscience.org/library/papers/38821614 | PubMed |
| 12 | 15001579 | The low density lipoprotein receptor-related protein is a motogenic receptor for plasminogen activator inhibitor-1. | J Biol Chem | 2004 | https://conductscience.org/library/papers/15001579 | PubMed |
| 13 | 39543686 | A signaling pathway map of plasminogen activator inhibitor-1 (PAI-1/SERPINE-1): a review of an innovative frontier in molecular aging and cellular senescence. | Cell Commun Signal | 2024 | https://conductscience.org/library/papers/39543686 | PubMed |
| 14 | 30419600 | The Urokinase Plasminogen Activator System in Human Cancers: An Overview of Its Prognostic and Predictive Role. | Thromb Haemost | 2018 | https://conductscience.org/library/papers/30419600 | PubMed |
| 15 | 41658172 | Visualizing Cytoskeletal Protein Reconstruction of Vulvar Cancer with Surface-Enhanced Raman Spectroscopy and Gold Nanoparticles. | ACS Omega | 2026 | https://conductscience.org/library/papers/41658172 | PubMed |
| 16 | 15386352 | Prognostic relevance of TGF-beta1 and PAI-1 in cervical cancer. | Int J Cancer | 2004 | https://conductscience.org/library/papers/15386352 | PubMed |
| 17 | 29980281 | Somatic mutation profiling of vulvar cancer: Exploring therapeutic targets. | Gynecol Oncol | 2018 | https://conductscience.org/library/papers/29980281 | PubMed |
| 18 | 23097597 | Cell surface remodeling by plasmin: a new function for an old enzyme. | J Biomed Biotechnol | 2012 | https://conductscience.org/library/papers/23097597 | PubMed |
| 19 | 35119068 | The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer. | Clin Sci (Lond) | 2022 | https://conductscience.org/library/papers/35119068 | PubMed |
| 20 | 11266468 | The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies. | J Cell Biol | 2001 | https://conductscience.org/library/papers/11266468 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ANXA5 | 308 | PubTator's text mining | https://conductscience.org/library/genes/308 | NCBI Gene |
| GPER1 | 2852 | PubTator's text mining | https://conductscience.org/library/genes/2852 | NCBI Gene |
| PLG | 5340 | PubTator's text mining | https://conductscience.org/library/genes/5340 | NCBI Gene |
| SERPINE1 | 5054 | PubTator's text mining | https://conductscience.org/library/genes/5054 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42379802
GET https://conductscience.org/api/papers/v1/42379802/references?page=2